← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2003Last known activity
Jul 1, 2023
Timeline
1980s
- Jun 1, 1985
Kessler Foundation— Founded
Drugs by trial phase (18 distinct, 18 trials)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Aphasia
- Autonomic Dysreflexia
- Brain Injuries
- Brain Injuries, Traumatic
- Dementia
- Dementia, Vascular
- Fatigue
- Hypotension
- Memory Disorders
- Multiple Sclerosis
- Rotator Cuff Injuries
- Sclerosis
- Shoulder Impingement Syndrome
- Shoulder Pain
- Spinal Cord Injuries
- Stroke
- Syndrome
- Tendinopathy
- Urinary Bladder, Neurogenic
- Wounds and Injuries
Recent trials (36)
- NCT05839652CollaboratorPhase 4Jul 1, 2023
- NCT04989660Lead sponsorPhase 4Aug 31, 2021
- NCT04136743Lead sponsorPhase 2Jun 14, 2019
- NCT03187795Overall official - principal investigatorPhase 2Jul 5, 2017
- NCT03187795Lead sponsorPhase 2Jul 5, 2017
- NCT03187795Reponsible party - principal investigatorPhase 2Jul 5, 2017
- NCT03167138Overall official - principal investigatorEarly Phase 1Jun 1, 2017
- NCT03167138Lead sponsorEarly Phase 1Jun 1, 2017
- NCT03167138Reponsible party - principal investigatorEarly Phase 1Jun 1, 2017
- NCT02893553CollaboratorPhase 2Dec 1, 2016
- NCT02317640Reponsible party - principal investigatorPhase 1/Phase 2Aug 1, 2016
- NCT02317640Lead sponsorPhase 1/Phase 2Aug 1, 2016
- NCT02317640Overall official - principal investigatorPhase 1/Phase 2Aug 1, 2016
- NCT02286557Lead sponsorPhase 2Oct 1, 2014
- NCT02307565CollaboratorPhase 3Mar 1, 2014
Details
- Founded
- East Hanover, NJ, US Jun 1, 1985
- Last known activity
- Jul 1, 2023